Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure.

Journal of acquired immune deficiency syndromes (1999) - 1 Aug 2007

De Luca Andrea, Weidler Jodi, Di Giambenedetto Simona, Coakley Eoin, Cingolani Antonella, Bates Michael, Lie Yolanda, Pesano Rick, Cauda Roberto, Schapiro Jonathan

Abstract excerpt

BACKGROUND: The extent to which HIV-1 replication capacity (RC) influences the response to therapy remains to be established. METHODS: Phenotypic susceptibility and RC of baseline isolates (n = 139) from patients enrolled in the ARGENTA trial were measured and correlated to treatment outcomes over 36 months. RESULTS: RC in baseline isolates correlated with the number of phenotypically active drugs (R = 0.34, P <...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to RNA, Viral

Share to Treatment Failure

Share to Virus Replication

Source

Identifiers

PMID: 17554216
DOI: 10.1097/QAI.0b013e318074f008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure.PMID 17554216Read ↗

Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patients.Semantic proximity Read ↗

The role of phenotyping and replication capacity in anti-HIV therapeutics.Semantic proximity Read ↗

Higher CD4+T Cell Counts Associated with Low ViralpolReplication Capacity among Treatment‐Naive Adults in Early HIV‐1 InfectionSemantic proximity Read ↗

Only slight impact of predicted replicative capacity for therapy response prediction.Semantic proximity Read ↗

Resistance and replication capacity assays: clinical utility and interpretation.Semantic proximity Read ↗

Assessing predicted HIV-1 replicative capacity in a clinical setting.Semantic proximity Read ↗

Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.Semantic proximity Read ↗

Phenotypic testing predicts virological response in successive protease inhibitor-based regimens.Semantic proximity Read ↗

Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults.Semantic proximity Read ↗

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure.Semantic proximity Read ↗

Differential impact of resistance-associated mutations to protease inhibitors and nonnucleoside reverse transcriptase inhibitors on HIV-1 replication capacity.Semantic proximity Read ↗

Practical applications of viral fitness in clinical practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.